Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
RENN Fund, Inc., formerly known as Renaissance Capital Growth & Income Fund III, is a publicly traded closed-end investment fund. The fund primarily targets investments in small-cap and micro-cap companies, providing capital through equity, convertible securities, and debt instruments. Historically, the fund has maintained a significant focus on the healthcare, biotechnology, and technology sectors, supporting emerging companies through various stages of growth. Since 2017, the fund has been managed by Horizon Kinetics Asset Management LLC, which oversees its portfolio and investment strategy. It is listed on the NYSE American exchange under the ticker symbol RENN.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Renaissance Capital Growth & Income Fund III.